96 related articles for article (PubMed ID: 15341023)
1. Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females.
Yin PH; Lee HC; Chau GY; Liu TY; Liu HC; Lui WY; Chi CW
Cancer Lett; 2004 Aug; 212(2):195-201. PubMed ID: 15341023
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients.
Rossi L; Leveri M; Gritti C; De Silvestri A; Zavaglia C; Sonzogni L; Silvestri L; Civardi E; Mondelli MU; Silini EM
J Hepatol; 2003 Oct; 39(4):564-70. PubMed ID: 12971967
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women.
Gorai I; Tanaka K; Inada M; Morinaga H; Uchiyama Y; Kikuchi R; Chaki O; Hirahara F
J Clin Endocrinol Metab; 2003 Feb; 88(2):799-803. PubMed ID: 12574216
[TBL] [Abstract][Full Text] [Related]
7. Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population.
Syamala VS; Syamala V; Sheeja VR; Kuttan R; Balakrishnan R; Ankathil R
Cancer Invest; 2010 Mar; 28(3):304-11. PubMed ID: 19863350
[TBL] [Abstract][Full Text] [Related]
8. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer.
Garner EI; Stokes EE; Berkowitz RS; Mok SC; Cramer DW
Cancer Res; 2002 Jun; 62(11):3058-62. PubMed ID: 12036914
[TBL] [Abstract][Full Text] [Related]
10. CYP17 and COMT gene polymorphisms can influence bone directly, or indirectly through their effects on endogenous sex steroids, in postmenopausal Japanese women.
Gorai I; Inada M; Morinaga H; Uchiyama Y; Yamauchi H; Hirahara F; Chaki O
Bone; 2007 Jan; 40(1):28-36. PubMed ID: 16971197
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
[TBL] [Abstract][Full Text] [Related]
12. CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women.
Juo SH; Wang TN; Lee JN; Wu MT; Long CY; Tsai EM
Hum Reprod; 2006 Jun; 21(6):1498-502. PubMed ID: 16527884
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.
Yu MW; Chiu YH; Yang SY; Santella RM; Chern HD; Liaw YF; Chen CJ
Br J Cancer; 1999 May; 80(3-4):598-603. PubMed ID: 10408872
[TBL] [Abstract][Full Text] [Related]
14. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
15. Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction.
Sata F; Yamada H; Suzuki K; Saijo Y; Yamada T; Minakami H; Kishi R
Pharmacogenet Genomics; 2006 Nov; 16(11):775-81. PubMed ID: 17047485
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.
Hefler LA; Tempfer CB; Grimm C; Lebrecht A; Ulbrich E; Heinze G; Leodolter S; Schneeberger C; Mueller MW; Muendlein A; Koelbl H
Cancer; 2004 Jul; 101(2):264-9. PubMed ID: 15241822
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
Sangrajrang S; Sato Y; Sakamoto H; Ohnami S; Laird NM; Khuhaprema T; Brennan P; Boffetta P; Yoshida T
Int J Cancer; 2009 Aug; 125(4):837-43. PubMed ID: 19415745
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
20. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
